Contents
Chair
Rodolphe Barrangou
Website: http://www.nasonline.org/member-directory/members/20044136.html
Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, USA.
Member of the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Inventors;
Co-Founder and Chief Executive Officer of CRISPR Biotechnologies;
Co-Founder and Chief Scientific Officer of Ancilia Biosciences;
Co-Founder, President and Chief Scientific Officer of TreeCo;
Co-Founder and member of the Scientific Advisory Board of Intellia Therapeutics.
Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, USA.
Member of the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Inventors;
Co-Founder and Chief Executive Officer of CRISPR Biotechnologies;
Co-Founder and Chief Scientific Officer of Ancilia Biosciences;
Co-Founder, President and Chief Scientific Officer of TreeCo;
Co-Founder and member of the Scientific Advisory Board of Intellia Therapeutics.
Dr. Barrangou was elected as a member into the National Academy of Sciences in 2018. He was also elected into the National Academy of Engineering in 2019 for the discovery of CRISPR-Cas genome editing and engineering microbes, plants, and animals for food and other applications. He was nominated among the highly cited researchers for 9 years in a row (2014-2022, Top 1% citations by year of publication in one or more fields, Web of Science™). He received multiple honors and awards for his early work on CRISPR, including the 2016 Warren Alpert Prize, the 2016 Canada Gairdner International Award, the 2017 NAS Award in Molecular Biology, and the 2018 NAS Prize in Food and Agriculture Sciences.
Dr. Barrangou is focusing on the characterization of CRISPR-Cas systems, and their applications in bacteria. The CRISPRlab has published numerous studies on the various applications of CRISPR-Cas systems, and illustrated their use for the study and development of probiotics, including for genotyping, phage resistance, and genome editing to understand and enhance health-promoting functions of interest. The work has spanned basic scientific to understand and decipher the genomics of lactic acid bacteria, as well as developing novel technologies and applying them to develop and formulate next-generation probiotic strains.
Dr. Barrangou is focusing on the characterization of CRISPR-Cas systems, and their applications in bacteria. The CRISPRlab has published numerous studies on the various applications of CRISPR-Cas systems, and illustrated their use for the study and development of probiotics, including for genotyping, phage resistance, and genome editing to understand and enhance health-promoting functions of interest. The work has spanned basic scientific to understand and decipher the genomics of lactic acid bacteria, as well as developing novel technologies and applying them to develop and formulate next-generation probiotic strains.
Speaker(s)
Dr. Rodolphe Barrangou
Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, USA.
Topic: Editing the microbiome and virome with CRISPR
Topic: Editing the microbiome and virome with CRISPR
Dr. David Bikard
Synthetic Biology Group, Department of Microbiology, Institut Pasteur & Eligo Biosciences, Paris, France.
Topic: In situ editing of gut bacteria
Topic: In situ editing of gut bacteria
Dr. Ben Adler
University of California & Innovative Genomics Institute, Berkeley, United States.
Topic: Phage genome engineering using CRISPR-Cas13a
Topic: Phage genome engineering using CRISPR-Cas13a
Meichen Pan
Department of Genetics and Genomics, North Carolina State University, Raleigh, NC, USA.
Topic: Engineering gut bifidobacteria
Topic: Engineering gut bifidobacteria
Programme
Programme
- Time (GMT-5)
- Chair/Speakers
- Topic
- 9:00-9:10
- Rodolphe Barrangou
- Welcoming Address
- 9:10-9:40
- Rodolphe Barrangou
- Editing the microbiome and virome with CRISPR
- 9:40-9:50
- /
- Q&A Session
- 9:50-10:20
- Meichen Pan
- Engineering gut bifidobacteria
- 10:20-10:30
- /
- Q&A Session
- 10:30-11:00
- David Bikard
- In situ editing of gut bacteria
- 11:00-11:10
- /
- Q&A Session
- 11:10-11:40
- Ben Adler
- Phage genome engineering using CRISPR-Cas13a
- 11:40-11:50
- /
- Q&A Session
- 11:50-12:00
- Rodolphe Barrangou
- Concluding Comments
Presentation
Rodolphe Barrangou, Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, USA.
Topic: Editing the microbiome and virome with CRISPR
NaN
Meichen Pan, Department of Genetics and Genomics, North Carolina State University, Raleigh, NC, USA.
Topic: CRISPR-based genome engineering in Bifidobacterium
NaN
Ben Adler, University of California & Innovative Genomics Institute, Berkeley, United States.
Topic: Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing
NaN
